Abstract:Association between microRNA (miRNA) expression signatures and atrial fibrillation has been evaluated with inconsistent findings in different studies. This study aims to identify miRNAs that actually play vital role in pathophysiological process of atrial fibrillation and explore miRNA-targeted genes and the involved pathways. Relevant studies were retrieved from the electronic databases of Embase, Medline, and Cochrane Library to determine the miRNA expression profiles between atrial fibrillation subjects and non-atrial fibrillation controls. Robustness of results was assessed using sensitivity analysis. Subgroup analyses were performed based on species, miRNA detection method, sample source, and ethnicity. Quality assessment of studies was independently conducted according to QUADAS-2. Bioinformatics analysis was applied to explore the potential genes and pathways associated with atrial fibrillation, which were targeted by differentially expressed miRNAs. Form of pooled results was shown as log10 odds ratios (logORs) with 95% confidence intervals (CI), and random-effects model was used. In total, 40 articles involving 283 differentially expressed miRNAs were reported. And 51 significantly dysregulated miRNAs were identified in consistent direction, with 22 upregulated and 29 downregulated. Among above-mentioned miRNAs, miR-223-3p (logOR 6.473; P < 0.001) was the most upregulated, while miR-1-5p (logOR 7.290; P < 0.001) was the most downregulated. Subgroup analysis confirmed 53 significantly dysregulated miRNAs (21 upregulated and 32 downregulated) in cardiac tissue, with miRNA-1-5p and miRNA-223-3p being the most upregulated and downregulated miRNAs, respectively. Additionally, miR-328 and miR-1-5p were highly blood-specific, and miR-133 was animal-specific. In the detection method sub-groups, miRNA-29b and miRNA-223-3p were differentially expressed consistently. Four miRNAs, including miRNA-223-3p, miRNA-21, miRNA-328, and miRNA-1-5p, were consistently dysregulated in both Asian and non-Asian. Results of sensitivity analysis showed that 47 out of 51 (92.16%) miRNAs were dysregulated consistently. Totally, 51 consistently dysregulated miRNAs associated with atrial fibrillation were confirmed in this study. Five important miRNAs, including miR-29b, miR-328, miR-1-5p, miR-21, and miR-223-3p may act as potential biomarkers for atrial fibrillation. Impact statement Atrial fibrillation (AF) is considered as the most common arrhythmia, and it subsequently causes serious complications including thrombosis and heart failure that increase the social burden. The definite mechanisms underlying AF pathogenesis remain complicated and unclear. Many studies attempted to discover the transcriptomic changes using microarray technologies, and the present studies for this hot topic have assessed individual miRNAs profiles for AF. However, results of different articles are controversial and not each reported miRNA is actually associated with the pathogenesis of AF. The present systematic review and meta-analysis identified that 51 consistently dysregulated miRNAs were associated with AF. Of these miRNAs, five miRNAs (miRNA-1-5p, miRNA-328, miRNA-29b, miRNA-21, and miRNA-223-3p) may act as novel biomarkers for AF. The findings could offer a better description of the biological characteristics of miRNAs, meanwhile might serve as new target for the intervention and monitoring AF in future studies.

Identification of Microrna Biomarkers in Atrial Fibrillation

Identification of Microrna Biomarkers in Atrial Fibrillation A Protocol for Systematic Review and Bioinformatics Analysis

MicroRNA Expression Signatures of Atrial Fibrillation: the Critical Systematic Review and Bioinformatics Analysis

Identification of Micrornas and Genes As Biomarkers of Atrial Fibrillation Using a Bioinformatics Approach

MicroRNA Expression Signature in Atrial Fibrillation with Mitral Stenosis.

Identification of miR-1 and miR-499 in chronic atrial fibrillation by bioinformatics analysis and experimental validation

The Expression Levels of Plasma Micornas in Atrial Fibrillation Patients

Plasma Microrna Expression Profiling in Paitents with Atrial Fibrillation

Possible key microRNAs and corresponding molecular mechanisms for atrial fibrillation

Identification of microRNA-mRNA interactions in atrial fibrillation using microarray expression profiles and bioinformatics analysis

Identification of Circrna-Mirna-mrna Regulatory Network and Autophagy Interaction Network in Atrial Fibrillation Based on Bioinformatics Analysis

MicroRNAs and atrial fibrillation: new fundamentals.

Identifying Pivotal microRNAs and Target Genes Associated With the Pathogenesis of Atrial Fibrillation

Identification of Pivotal MicroRNAs and Target Genes Associated with Persistent Atrial Fibrillation Based on Bioinformatics Analysis

Analysis of Potential Roles of Combinatorial Microrna Regulation in Occurrence of Valvular Heart Disease with Atrial Fibrillation Based on Computational Evidences.

Unveiling Clinical Biomarkers and Therapeutic Avenues in Atrial Fibrillation and Associated Stroke—A Systematic Review

microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation

Identifying Pivotal microRNAs&nbsp;and Target Genes Associated With the Pathogenesis of Atrial Fibrillation

Identification of Atrial Fibrillation-Associated Micrornas in Left and Right Atria of Rheumatic Mitral Valve Disease Patients.

microRNAs as the predictors for atrial fibrillation recurrence after catheter ablation: next-generation sequencing study

Identification of Atrial Fibrillation-Related Circular RNAs and Constructing the Integrative Regulatory Network of Circular RNAs, Micrornas and Mrnas by Bioinformatics Analysis.